Delivery Order SPE2DR25D3005-SPE2DR26FP7FX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,553.93 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) under a firm fixed price arrangement. The delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $15,967.36 delivery order to AmerisourceBergen Drug Corp for 28 Imbruvica 70 mg capsules on November 17, 2025, with completion targeted for December 9, 2025. This firm fixed-price delivery order utilizes no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Imbruvica 280 mg tablets (28-count) with a completion date of December 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $16,233.74 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price, competitively awarded delivery order was placed without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $8,553.93 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 140 mg capsules (90-count) under a firm fixed-price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by November 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on August 18, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Imbruvica 140 mg capsules (120-count units) with a ceiling value of $10,822.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by November 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a ceiling value of $24,350.61. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, was competitively awarded without a set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a ceiling value of $8,116.87. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMBRUVICA 140 mg capsules (90-count units) with a ceiling value of $16,233.74. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7FXDelivery Order
The Defense Logistics Agency awarded a $8,553.93 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a completion deadline of December 9, 2025. This firm fixed-price contract, awarded without set-aside designation, reflects a competitive procurement executed under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The award is issued to the contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction within AmerisourceBergen's substantial $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for global pharmaceutical support to military healthcare systems through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support Defense Health Agency operations and other government healthcare entities. The Imbruvica order aligns with the company's established portfolio of specialty medications and brand-name pharmaceuticals delivered through competitively awarded contracts with consistent firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 11/17/25 |